ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 180 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $297,741 | -68.0% | 46,090 | -62.6% | 0.01% | -73.9% |
| Q1 2023 | $929,411 | -21.0% | 123,264 | +6.2% | 0.02% | -30.3% |
| Q4 2022 | $1,176,113 | +51.2% | 116,102 | +47.6% | 0.03% | +43.5% |
| Q3 2022 | $778,000 | +91.6% | 78,638 | +176.7% | 0.02% | +76.9% |
| Q4 2021 | $406,000 | -72.3% | 28,415 | -61.1% | 0.01% | -78.0% |
| Q3 2021 | $1,464,000 | +161.0% | 73,067 | +186.7% | 0.06% | +145.8% |
| Q2 2021 | $561,000 | – | 25,488 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |